Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Analysis of Macritonin phase II/III trial complete; Cortecs to seek European approval

Aug. 11, 1997

Etidronate reduces fractures in corticosteroid-induced osteoporosis

Aug. 11, 1997

Vanadium compounds for treatment of diabetes

Aug. 8, 1997

New HRT option from Organon

Aug. 8, 1997

Atypical beta-adrenoceptor agonists from Glaxo Wellcome

Aug. 7, 1997

Oxygen carrier tested in patients with sickle cell disease

Aug. 7, 1997

Medicare policy slows Epogen sales

Aug. 6, 1997

Knoll reaches settlement on Synthroid class action lawsuit

Aug. 6, 1997

GnRH antagonists in the pipeline at Merck & Co.

Aug. 6, 1997

New direction in NOS research: Potential application in gene therapy of impotence

Aug. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...